Table 4.
Day | vMyx-WT and Revertants | vMyx-MT5KO | vMyx-148–150KO | vMyx-ANKsKO |
---|---|---|---|---|
0 | Inoculation of two rabbits intradermally with 1,000 PFU or FFU for each of the following viruses: vMyx-WT Lausanne, vMyx-MT5KO Revertant, vMyx 148–150 Revertant, vMyx-ANKsKO Revertant | Inoculation of three rabbits intradermally with 1,000 FFU of vMyx-MT5KO | Inoculation of four rabbits intradermally with 1,000 FFU of vMyx-148–150KO | Inoculation of four rabbits intradermally with 1,000 FFU of vMyx-ANKsKO |
4 | Primary lesions at inoculation sites: 2.0–3.0 cm (8/8) Raised, soft, red lesions (4/8) Raised, red, necrotic lesions (4/8) Multiple secondary lesions on ears (5/8) |
Primary lesions at inoculation sites: Raised, soft, red (ca 2.0–2.5 cm) (3/3) | Primary lesions at inoculation sites: Raised, soft, red (ca 2.0–2.5 cm) (4/4) One rabbit exhibited minute secondary lesions on the ear |
Primary lesions at inoculation sites: Raised, soft, red (ca. 1.5–2.5 cm) (4/4) |
7 | Primary lesions red, swollen, necrotic (4.0–5.0 cm) 8/8 Multiple secondary myxomas in the eyes, ears, and nose. (8/8) Gram-negative bacteria infections of conjunctivas (7/8) |
Primary lesions red, swollen, necrotic, healing (2.0–2.5 cm) (3/3) | Primary lesions red, swollen, necrotic (ca 3.5–5.0 cm) (4/4) Multiple minute secondary myxomas (4/4), gram-negative bacterial infections of conjunctivas (2/4) |
Primary lesions red, swollen, necrotic (ca. 1.5–2.0 cm) (4/4) |
9–10 | Primary lesions red, swollen, necrotic (5.0–6.0 cm) (8/8) Multiple secondary myxomas, turning necrotic, dyspnea, severe infections of respiratory tracts, prostrated and emaciated animals. All rabbits were sacrificed due to the severity of symptoms |
Primary lesions swollen, but healing | Primary lesions swollen, but healing Secondary lesions healing (4/4) | Primary lesions swollen, but healing |
17 | Full regression of primary lesions | Full regression of primary and secondary lesions | Full regression of primary lesions |